X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with Lupin Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs LUPIN LTD - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA LUPIN LTD FULFORD INDIA/
LUPIN LTD
 
P/E (TTM) x 398.8 161.7 246.6% View Chart
P/BV x 6.2 3.0 206.7% View Chart
Dividend Yield % 0.1 0.8 10.2%  

Financials

 FULFORD INDIA   LUPIN LTD
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
LUPIN LTD
Mar-17
FULFORD INDIA/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs9421,750 53.8%   
Low Rs4501,384 32.5%   
Sales per share (Unadj.) Rs691.4387.4 178.5%  
Earnings per share (Unadj.) Rs11.556.6 20.2%  
Cash flow per share (Unadj.) Rs15.476.8 20.0%  
Dividends per share (Unadj.) Rs2.007.50 26.7%  
Dividend yield (eoy) %0.30.5 60.0%  
Book value per share (Unadj.) Rs380.0298.9 127.1%  
Shares outstanding (eoy) m3.90451.58 0.9%   
Bonus/Rights/Conversions -ESOPS-  
Price / Sales ratio x1.04.0 24.9%   
Avg P/E ratio x60.727.7 219.5%  
P/CF ratio (eoy) x45.320.4 222.2%  
Price / Book Value ratio x1.85.2 34.9%  
Dividend payout %17.413.2 131.8%   
Avg Mkt Cap Rs m2,714707,513 0.4%   
No. of employees `0000.416.8 2.6%   
Total wages/salary Rs m50528,495 1.8%   
Avg. sales/employee Rs Th6,073.010,418.3 58.3%   
Avg. wages/employee Rs Th1,137.41,697.0 67.0%   
Avg. net profit/employee Rs Th100.71,523.0 6.6%   
INCOME DATA
Net Sales Rs m2,696174,943 1.5%  
Other income Rs m1251,065 11.8%   
Total revenues Rs m2,822176,008 1.6%   
Gross profit Rs m-4644,931 -0.1%  
Depreciation Rs m159,122 0.2%   
Interest Rs m101,525 0.6%   
Profit before tax Rs m5435,349 0.2%   
Minority Interest Rs m0-72 0.0%   
Prior Period Items Rs m083 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m109,785 0.1%   
Profit after tax Rs m4525,575 0.2%  
Gross profit margin %-1.725.7 -6.7%  
Effective tax rate %17.727.7 63.9%   
Net profit margin %1.714.6 11.3%  
BALANCE SHEET DATA
Current assets Rs m1,738119,542 1.5%   
Current liabilities Rs m54561,206 0.9%   
Net working cap to sales %44.333.3 132.8%  
Current ratio x3.22.0 163.4%  
Inventory Days Days4876 63.8%  
Debtors Days Days490 4.8%  
Net fixed assets Rs m12131,660 0.0%   
Share capital Rs m39903 4.3%   
"Free" reserves Rs m1,443134,073 1.1%   
Net worth Rs m1,482134,976 1.1%   
Long term debt Rs m056,478 0.0%   
Total assets Rs m2,077266,073 0.8%  
Interest coverage x6.724.2 27.8%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x1.30.7 197.5%   
Return on assets %2.610.2 25.6%  
Return on equity %3.018.9 15.9%  
Return on capital %4.319.3 22.3%  
Exports to sales %00-   
Imports to sales %24.50-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m659NA-   
Fx inflow Rs m1781,885 0.0%   
Fx outflow Rs m67321,506 3.1%   
Net fx Rs m-65660,378 -1.1%   
CASH FLOW
From Operations Rs m9041,148 0.2%  
From Investments Rs m105-25,287 -0.4%  
From Financial Activity Rs m-144,332 -0.3%  
Net Cashflow Rs m18120,193 0.9%  

Share Holding

Indian Promoters % 0.0 46.6 -  
Foreign collaborators % 75.0 0.2 37,500.0%  
Indian inst/Mut Fund % 3.8 11.3 33.6%  
FIIs % 0.1 31.9 0.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 10.1 209.9%  
Shareholders   4,783 98,259 4.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   AJANTA PHARMA  GLENMARK PHARMA  SUN PHARMA  STRIDES SHASUN LTD  FDC LTD.  

Compare FULFORD INDIA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Rising Oil Prices; RBI Minutes and Top Stocks in Action Today(Pre-Open)

Indian share markets surged on Wednesday, snapping a two-day losing streak led by gains Reliance Industries and bank stocks.

Related Views on News

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 8-QTR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS